BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29934276)

  • 21. Relationship between signal intensity on hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MR imaging and prognosis of borderline lesions of hepatocellular carcinoma.
    Kobayashi S; Matsui O; Gabata T; Koda W; Minami T; Ryu Y; Kozaka K; Kitao A
    Eur J Radiol; 2012 Nov; 81(11):3002-9. PubMed ID: 22748558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of combined Gd-EOB-DTPA and gadobutrol magnetic resonance imaging for the prediction of hepatocellular carcinoma grading.
    Schelhorn J; Best J; DechĂȘne A; Göbel T; Bertram S; Lauenstein T; Kinner S
    Acta Radiol; 2016 Aug; 57(8):932-8. PubMed ID: 26586852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Hepatic Toxicity after Repeated Stereotactic Body Radiation Therapy for Recurrent Hepatocellular Carcinoma using Deformable Image Registration.
    Lee S; Kim H; Ji Y; Cho B; Kim SS; Jung J; Kwak J; Park JH; Lee SW; Kim JH; Yoon SM
    Sci Rep; 2018 Nov; 8(1):16224. PubMed ID: 30385839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure guided deformable image registration for treatment planning CT and post stereotactic body radiation therapy (SBRT) Primovist
    Kuznetsova S; Grendarova P; Roy S; Sinha R; Thind K; Ploquin N
    J Appl Clin Med Phys; 2019 Dec; 20(12):109-118. PubMed ID: 31755658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomy.
    Toyoda H; Kumada T; Tada T; Niinomi T; Ito T; Sone Y; Kaneoka Y; Maeda A
    J Hepatol; 2013 Jun; 58(6):1174-80. PubMed ID: 23376360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-Up.
    Mendiratta-Lala M; Masch W; Shankar PR; Hartman HE; Davenport MS; Schipper MJ; Maurino C; Cuneo KC; Lawrence TS; Owen D
    Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):169-179. PubMed ID: 30213751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC.
    Toyoda H; Kumada T; Tada T; Sone Y; Maeda A; Kaneoka Y
    Hepatol Int; 2015 Jan; 9(1):84-92. PubMed ID: 25788383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma.
    Ariizumi S; Kitagawa K; Kotera Y; Takahashi Y; Katagiri S; Kuwatsuru R; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):575-85. PubMed ID: 21360083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of diffusion-weighted imaging and gadoxetic acid-enhanced MR images in the evaluation of hepatocellular carcinoma and hypovascular hepatocellular nodules.
    Di Pietropaolo M; Briani C; Federici GF; Marignani M; Begini P; Delle Fave G; Iannicelli E
    Clin Imaging; 2015; 39(3):468-75. PubMed ID: 25748089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
    Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES
    Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Timing of the hepatic arterial phase at Gd-EOB-DTPA-enhanced hepatic dynamic MRI: comparison of the test-injection and the fixed-time delay method.
    Nakamura S; Nakaura T; Kidoh M; Utsunomiya D; Doi Y; Harada K; Uemura S; Yamashita Y
    J Magn Reson Imaging; 2013 Sep; 38(3):548-54. PubMed ID: 23744782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gd-EOB-DTPA-enhanced MRI is better than MDCT in decision making of curative treatment for hepatocellular carcinoma.
    Yoo SH; Choi JY; Jang JW; Bae SH; Yoon SK; Kim DG; Yoo YK; Rha SE; Lee YJ; Jung ES
    Ann Surg Oncol; 2013 Sep; 20(9):2893-900. PubMed ID: 23649931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with Gd-EOB-DTPA to detect small hepatocellular carcinoma.
    Kunishi Y; Numata K; Morimoto M; Okada M; Kaneko T; Maeda S; Tanaka K
    AJR Am J Roentgenol; 2012 Jan; 198(1):106-14. PubMed ID: 22194485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different signal intensity at Gd-EOB-DTPA compared with Gd-DTPA-enhanced MRI in hepatocellular carcinoma transgenic mouse model in delayed phase hepatobiliary imaging.
    Korkusuz H; Knau LL; Kromen W; Bihrer V; Keese D; Piiper A; Vogl TJ
    J Magn Reson Imaging; 2012 Jun; 35(6):1397-402. PubMed ID: 22267126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MR imaging of carcinosarcoma of the liver using Gd-EOB-DTPA.
    Yasutake T; Kiryu S; Akai H; Watadani T; Akahane M; Tomizawa N; Gonoi W; Ikemura M; Takahashi M; Matsuoka Y; Ohtomo K
    Magn Reson Med Sci; 2014; 13(2):117-21. PubMed ID: 24769633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TWIST-VIBE five-arterial-phase technology decreases transient severe motion after bolus injection of Gd-EOB-DTPA.
    Li H; Xiao Y; Wang S; Li Y; Zhong X; Situ W; Xiao E; Zhang Z
    Clin Radiol; 2017 Sep; 72(9):800.e1-800.e6. PubMed ID: 28476245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiparametric Gd-EOB-DTPA magnetic resonance in diagnosis of HCC: dynamic study, hepatobiliary phase, and diffusion-weighted imaging compared to histology after orthotopic liver transplantation.
    Faletti R; Cassinis MC; Fonio P; Bergamasco L; Pavan LJ; Rapellino A; David E; Gandini G
    Abdom Imaging; 2015 Jan; 40(1):46-55. PubMed ID: 24965896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health economic evaluation of Gd-EOB-DTPA MRI vs ECCM-MRI and multi-detector computed tomography in patients with suspected hepatocellular carcinoma in Thailand and South Korea.
    Lee JM; Kim MJ; Phongkitkarun S; Sobhonslidsuk A; Holtorf AP; Rinde H; Bergmann K
    J Med Econ; 2016 Aug; 19(8):759-68. PubMed ID: 27026278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
    Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
    J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging.
    Chen S; Feng S; Wei J; Liu F; Li B; Li X; Hou Y; Gu D; Tang M; Xiao H; Jia Y; Peng S; Tian J; Kuang M
    Eur Radiol; 2019 Aug; 29(8):4177-4187. PubMed ID: 30666445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.